77 related articles for article (PubMed ID: 10851480)
1. The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy.
Dle Beato T; Berghella AM; Pellegrini P; Domenico A; Casciani CU
Cancer Biother Radiopharm; 1997 Oct; 12(5):297-304. PubMed ID: 10851480
[TBL] [Abstract][Full Text] [Related]
2. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.
Contasta I; Pellegrini P; Berghella AM; Del Beato T; Canossi A; Di Rocco M; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1996 Dec; 11(6):373-83. PubMed ID: 10851498
[TBL] [Abstract][Full Text] [Related]
3. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
[TBL] [Abstract][Full Text] [Related]
4. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
Contasta I; Berghella AM; Pellegrini P; Adorno D
Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of immunological evaluation in colorectal cancer.
Berghella AM; Pellegrini P; Del Beato T; Maccarone D; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1996 Dec; 11(6):355-61. PubMed ID: 10851496
[TBL] [Abstract][Full Text] [Related]
6. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
7. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
[TBL] [Abstract][Full Text] [Related]
9. Immunological directives for biotherapy improvement in the treatment of colorectal cancer.
Pellegrini P; Berghella AM; Del Beato T; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1996 Apr; 11(2):113-8. PubMed ID: 10851527
[TBL] [Abstract][Full Text] [Related]
10. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
[TBL] [Abstract][Full Text] [Related]
11. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2.
Velásquez SY; García LF; Opelz G; Alvarez CM; Süsal C
Transplantation; 2013 Jul; 96(2):154-61. PubMed ID: 23857000
[TBL] [Abstract][Full Text] [Related]
12. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
[TBL] [Abstract][Full Text] [Related]
13. The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer.
Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Cencioni S; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1997 Aug; 12(4):257-64. PubMed ID: 10851473
[TBL] [Abstract][Full Text] [Related]
14. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
15. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
16. Disease stage prognostic indices in the early clinical screening of colorectal cancer patients.
Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Casciani CU; Adorno D
Cancer Biother Radiopharm; 1998 Apr; 13(2):89-98. PubMed ID: 10850345
[TBL] [Abstract][Full Text] [Related]
17. CD30 expression on allergen- and non-allergen-specific T cell lines and its role in cytokine production.
Tarkowski M
Arch Immunol Ther Exp (Warsz); 2003; 51(5):335-43. PubMed ID: 14626433
[TBL] [Abstract][Full Text] [Related]
18. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
19. The effect of colorectal cancer upon host peripheral immune cell function.
Evans CF; Galustian C; Bodman-Smith M; Dalgleish AG; Kumar D
Colorectal Dis; 2010 Jun; 12(6):561-9. PubMed ID: 19250260
[TBL] [Abstract][Full Text] [Related]
20. Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.
Wu Q; Zhang J; Shi J; Ge M; Li X; Shao Y; Yao J; Zheng Y
PLoS One; 2014; 9(11):e110787. PubMed ID: 25383872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]